Annual General Meeting

GlaxoSmithKline plc (‘GSK’) holds an Annual General Meeting in London each year during May. All the directors able to attend are available formally during the meeting, and informally beforehand, for questions.

Voting on all resolutions put to the Annual General Meeting is done by way of a poll rather than by a show of hands.

2018 Annual General Meeting

The eighteenth Annual General Meeting (‘AGM’) of GSK was held on Thursday 3 May 2018 at the QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE.

The 2018 Notice of AGM gives details on the resolutions put to the meeting, together with explanatory notes.

All resolutions were passed at the AGM and the voting results can be found here.

In accordance with section 311A of the Companies Act 2006, GSK confirms that, as at 28 March 2018, its issued share capital (excluding Treasury shares) consisted of 4,958,943,485 ordinary shares of 25 pence each, carrying one vote each. Therefore, the total voting rights that members were entitled to exercise at the AGM in respect of these shares was 4,958,943,485.

Information about our previous Annual General Meetings is available from the AGM archive tab above.

Notice of Availability

2018 General Meeting – Buyout of Novartis’ interest in GlaxoSmithKline Consumer Healthcare Holdings Limited

Information on the General Meeting held on Thursday 3 May 2018 can be found here.